journal article·2011-07-08Open access

Synthesis and characterization of human transferrin-stabilized gold nanoclusters

Xavier Le Guével, Nicole Daum, Marc Schneider

Nanotechnology· Volume 22· Issue 27

Abstract

Human transferrin has been biolabelled with gold nanoclusters (Au NCs) using a simple, fast and non-toxic method. These nanocrystals (<2 nm) are stabilized in the protein via sulfur groups and have a high fluorescence emission in the near infrared region (QY=4.3%; λem=695 nm). Structural investigation and photophysical measurements show a high population of clusters formed of 22-33 gold atoms covalently bound to the transferrin. In solutions with pH ranging from 5 to 10 and in buffer solutions (PBS, HEPES), those biolabelled proteins exhibit a good stability. No significant quenching effect of the fluorescent transferrin has been detected after iron loading of iron-free transferrin (apoTf) and in the presence of a specific polyclonal antibody. Additionally, antibody-induced agglomeration demonstrates no alteration in the protein activity and the receptor target ability. MTT and Vialight® Plus tests show no cytotoxicity of these labelled proteins in cells (1 µg ml(-1)-1 mg ml(-1)). Cell line experiments (A549) indicate also an uptake of the iron loaded fluorescent proteins inside cells. These remarkable data highlight the potential of a new type of non-toxic fluorescent transferrin for imaging and targeting.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanocluster Synthesis and Applications · Gold and Silver Nanoparticles Synthesis and Applications · Quantum Dots Synthesis And Properties

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (39)

Show source-provided references
1. 10.1021/ja017822w10.1021/ja017822w ↗
2. 10.1002/jbm.a.3145010.1002/jbm.a.31450 ↗
3. 10.1021/nl070782v10.1021/nl070782v ↗
4. 10.1021/cr078384010.1021/cr0783840 ↗
5. 10.1021/nn800893310.1021/nn8008933 ↗
6. 10.1271/bbb.64.132810.1271/bbb.64.1328 ↗
7. 10.1124/pr.54.4.56110.1124/pr.54.4.561 ↗
8. 10.1529/biophysj.107.11463710.1529/biophysj.107.114637 ↗
9. 10.1016/S1359-6446(04)03333-110.1016/S1359-6446(04)03333-1 ↗
10. 10.1016/j.amjmed.2007.02.02710.1016/j.amjmed.2007.02.027 ↗
11. 10.1080/1071576031000160039010.1080/10715760310001600390 ↗
12. 10.1248/bpb.26.149410.1248/bpb.26.1494 ↗
13. 10.1126/science.281.5385.201610.1126/science.281.5385.2016 ↗
14. 10.1124/pr.57.4.210.1124/pr.57.4.2 ↗
15. 10.1016/j.ejps.2006.07.00410.1016/j.ejps.2006.07.004 ↗
16. 10.1021/bc049775d10.1021/bc049775d ↗
17. 10.1016/S0005-2736(97)00046-110.1016/S0005-2736(97)00046-1 ↗
18. 10.1126/science.110427410.1126/science.1104274 ↗
19. 10.1021/jp014259v10.1021/jp014259v ↗
20. Shiang Y C · Chem. Commun. · 2009 · 343710.1039/b901916b ↗
21. 10.1364/OE.17.01611110.1364/OE.17.016111 ↗
22. 10.1039/c0nr00377h10.1039/c0nr00377h ↗
23. 10.1021/ja809785s10.1021/ja809785s ↗
24. 10.1146/annurev.physchem.58.032806.10454610.1146/annurev.physchem.58.032806.104546 ↗
25. 10.1021/ja035473v10.1021/ja035473v ↗
26. 10.1021/ja806804u10.1021/ja806804u ↗
27. 10.1021/ac60289a01610.1021/ac60289a016 ↗
28. 10.1021/ac035348210.1021/ac0353482 ↗
29. 10.1021/ar960266410.1021/ar9602664 ↗
30. 10.1021/am900350r10.1021/am900350r ↗
31. 10.1016/j.elspec.2008.02.00510.1016/j.elspec.2008.02.005 ↗
32. 10.1016/j.bbabio.2007.06.00410.1016/j.bbabio.2007.06.004 ↗
33. 10.1016/S1381-1177(99)00030-210.1016/S1381-1177(99)00030-2 ↗
34. 10.1016/j.ab.2008.08.00610.1016/j.ab.2008.08.006 ↗
35. 10.1039/c0jm02660c10.1039/c0jm02660c ↗
36. Retnakumari A · Nanotechnology · 2010 · 21 · 05510310.1088/0957-4484/21/5/055103 ↗
37. Adams P C · Hepatology · 2006 · 44 · 432A-3A
38. 10.1002/chem.20090142510.1002/chem.200901425 ↗
39. 10.1016/j.clim.2006.06.00610.1016/j.clim.2006.06.006 ↗